Key Takeaways
Inhalant use disorder is a mental health condition where a person deliberately inhales chemicals typically found in household products, to achieve intoxication. The disorder is officially recognized as a substance use disorder in the DSM-5 and ranges from mild to severe.
Symptoms include cravings, loss of control, and continued use despite harmful consequences in health, relationships, or day-to-day responsibilities. Physical and behavioral signs may include dizziness, slurred speech, chemical odors, irritability, and withdrawal from daily activities.
Treatment typically combines behavioral therapies such as cognitive behavioral therapy, motivational interviewing, and support groups like Narcotics Anonymous. In more severe cases, inpatient rehabilitation, medical detoxification, and long-term aftercare may be necessary to maintain recovery.
Understanding Inhalant Use Disorder
Inhalant (or volatile substance) use disorder is a mental health condition officially recognized by the Diagnostic and Statistical Manual for Mental Disorders, Fifth Edition (DSM-5). IUD is classified as a substance use disorder (SUD) and occurs on a spectrum ranging from mild to severe, with moderate and severe cases also unofficially called “dependence” or “addiction.” [1]
While inhalant use disorder (IUD) is not as well-known as other substance use disorders, an individual can easily become addicted to volatile substances after intentionally inhaling these chemicals and experiencing the euphoria of intoxication. Inhalants are typically found in everyday household or workplace products, which are inexpensive and widely available. [1]
Due to the sheer volume of chemicals available without the need for identification, thousands of inhalants are misused globally, and these can be grouped into four categories: gases (eg. lighter gas), solvents (such as glue), aerosols (like deoderant), and nitrates or “poppers.” Inhaling these substances can instantly flood the brain with dopamine and trigger the cycle of addiction.
In light of the fact that inhalants can be found around nearly every corner in the form of unassuming domestic products, these substances are frequently abused by minors. While inhalant use disorder is a worldwide concern, vulnerability is influenced by social and economic conditions, leading to a high prevalence among marginalized populations.
Tragically, inhaling chemicals can be fatal, with just one time use having the potential to cause “sudden sniffing death” or suffocation. Despite these risks, volatile substance use disorder is often referred to as “the forgotten epidemic” because it is the least studied substance use disorder. That said, there are professional treatments available for IUD, and it is possible to recover and go on to live a fulfilling life. [1] [2]
How do Inhalants Affect the Brain?
Like all substance use disorders, IUD significantly disrupts the brain’s reward system, meaning that with frequent inhalant abuse, the brain becomes permanently rewired to crave intoxication repeatedly. This results in addiction, where using inhalants begins to take central priority in an individual’s life, leading to serious social and legal consequences along with severe health risks.
Research has revealed that long-term exposure to toluene (a chemical frequently found in glue, paint thinners, nail polish remover, spray paints, and more household products) affects brain chemistry in several ways, including adaptions in how certain brain receptors related to mood work. [3]
Animal studies have revealed that brain receptors involved in both reward and mood can increase in some areas and decrease in others. This occurs due to inhalants, like toluene, temporarily boosting dopamine and serotonin (the body’s natural feel-good chemicals), which influence mood and behavior. [3]
Over time, the brain becomes used to unnaturally high levels of these euphoria-inducing chemicals, which results in a reprogramming of the brain’s survival mechanism to seek intoxication in order to feel normal. For this reason, individuals regularly abusing inhalants develop both a mental obsession and physical cravings.
In severe cases, the only way to address this successfully is by creating a barrier between an addict and accessibility to the drug, in the form of a residential treatment program. However, individuals with milder forms of inhalant use disorder (who have not yet rewired the brain) could recover with therapy alone.
How Common are Inhalant Use Disorders?
While inhalant use disorder is not the most prevalent addiction in comparison to substances like nicotine, alcohol, cannabis, prescription medications, or cocaine, it is not only possible, but fairly common for individuals to become dependent on inhalants due to the effects that volatile substances have on the brain’s reward system.
In light of the fact that inhalants cause fast-acting but short-lived intoxication, most statistics surrounding prevalence focus on inhalant misuse rather than dependence. Additionally, the number of inhalant users may be higher as surveys often miss the groups at greatest risk, such as homeless youth or those not attending school. [3] [4]
Inhalant use also tends to come in waves or within specific communities, which makes it harder to measure accurately. Keeping this in mind, recent research indicates more than 22 million Americans above the age of 12 have tried inhalants at least once, with about 750,000 people beginning to abuse them each year. [3] [4]
In the United States of America, adolescents between the ages of 12 and 17 are most likely to abuse volatile substances, with just over 3.5% of 8th graders reporting misuse in 2021. Only a small number of individuals persist in using inhalants into adulthood, and in terms of IUD itself, only one in a thousand people is diagnosed with the disorder. [4]
Additionally, studies show that female adolescents account for 52% of reported young users, with males making up the remaining 48%. However, it should be noted that inhalant use among females tends to decline with age, while data suggests that male users are more likely to continue inhalant use beyond adolescence. [4]
Commonly Used Inhalants
With thousands of different types of chemical inhalants that can be abused, it is useful to group these into categories. The four types of inhalants that are commonly misused include gases, nitrates or “poppers,” solvents, and aerosols. Each of these rapidly produces short-lived intoxication and poses the risk of overdose, even with only one use.
The high from inhalants typically lasts only a few minutes, leading users to repeatedly inhale over several hours to prolong the effect. Inhalants are usually taken in through the nose or mouth by methods such as “sniffing,” “snorting,” “bagging,” or “huffing,” with the terms varying based on the type of substance and how it is inhaled.
Gases
Gaseous inhalants are substances that exist as gases at room temperature, and are inhaled to produce psychoactive effects. They are typically breathed in directly from a container, through a balloon or bag, or via small cartridges. Commonly abused gases include, but aren’t limited to:
Whippets: These are small nitrous oxide canisters, also known as laughing gas, commonly found in whipped cream dispensers.
Butane: Butane is found in lighters or gas refills, as well as in portable stoves, and torches, where it is stored under pressure and released as a flammable vapor.
Propane: Propane comes in small canisters, often used for camping stoves or heaters, where it is dispensed as a combustible gas.
Refrigerant Gas: Refrigerant gas is kept in containers for air conditioners or refrigerators and can be inhaled to create a brief euphoric effect.
Nitrites
Nitrates, colloqially known as “poppers,” are sold in small bottles, often used with the primary purpose of muscle relaxation and enhancing sexual experiences, rather than producing a conventional “high.” There are four common forms of poppers, including:
Amyl Nitrite: Amyl nitrite is typically sold in small, sealed glass vials or bottles, often clear or amber in color, with a screw or snap cap.
Butyl Nitrite: Butyl nitrite usually comes in small, cylindrical glass bottles, often labeled with colorful branding, and sealed with a plastic or metal cap.
Isobutyl Nitrite: Isobutyl nitrite is packaged in small, clear or tinted glass vials, sometimes with a dropper or screw top, and occasionally marketed as room deodorizers.
Cyclohexyl Nitrite: Cyclohexyl nitrite is found in small glass bottles, usually sealed tightly, and may have labels with brand names or warnings.
Solvents
Solvents are liquids that turn into gases at room temperature through evaporation, a process in which molecules at the surface gain enough energy to enter the air as vapors. This allows the gas to be inhaled, quickly entering the lungs and causing psychoactive effects in the brain.
Felt-Tip Markers: One of the most commonly abused inhalants, many adolescents sniff the ink of felt-tip markers to achieve a short-lived high.
Glue: Many glues contain the toluene, a chemical that is inhaled either directly from the original packaging or with a soaked cloth.
Paint Thinners: Paint thinners are liquids used to thin oil-based paints or clean paintbrushes and other painting tools. These are sniffed or “huffed” from a rag or cloth.
Nail Polish Remover: Most nail polish removers contain acetone, a chemical which (like other solvents) can be sniffed to induce intoxication.
Aerosols
Spray products are often inhaled through a towel or rag to breathe in the fumes, and are among the most dangerous method of inhalation. This is due to the fact that a person breathes in a much higher dose of chemicals at once, which increases the risk of sudden heart failure, suffocation, chemical burns to the lungs, or brain damage.
Some of the most commonly abused aerosols include:
Deodorant
Hair Spray
Air Freshener
Vegetable Oil Spray
Cooking Spray
Spray Paint
Furniture Polish
Insect Spray
Fabric Refresher Sprays
##
Signs and Symptoms of Inhalant Addiction
According to the DSM-5, a person can be diagnosed with inhalant use disorder when an individual has used these chemicals in a manner that leads to negative consequences in their life. Like other substance use disorders, the criteria specify that at least two of the following behaviors must have occurred within a year: [5]
DSM-5 Symptoms for Inhalant Use Disorder
Using inhalants in greater quantities or over longer periods of time than originally intended.
Being unable to cut down or control inhalant use despite repeated attempts.
Spending a significant amount of time obtaining, using, or recovering from inhalants.
Experiencing strong cravings or urges to use inhalants.
Failing to meet obligations at work, school, or home due to inhalant use.
Continuing inhalant use despite directly related problems in relationships or social situations.
Abandoning activities that support occupational growth, hobbies, or social engagement in favor of inhalant use.
Using inhalants in dangerous or unsafe situations (eg. driving while intoxicated).
Persisting in using inhalants despite conscious awareness that continued use will inevitably worsen mental or physical health issues.
Developing tolerance (requiring increasing quantities to achieve the same effect).
Signs of Inhalant Dependence
The National Library of Medicine, well-renowned for being the world’s most comprehensive medical library, notes that inhalant dependence can lead to physical, psychological, and behavioral signs in addition to the official DSM-5 symptoms. These are often noticeable to those around the addicted individual, even when the person with IUD is not aware of them.
Physical Signs
Nausea
Fatigue
Slurred speech
Chemical scent on clothes or the breath
Stains on the hands, face, or clothing
Irritated (red) eyes, nasal discharge, or nosebleeds
Sores or ulcers around the mouth and nose
Poor coordination or clumsiness
Hidden empty solvent containers, rags, towels, or chemical-soaked clothing
Psychological Signs
Irritability
Disorientation
Depressed mood
Difficulty concentrating
Hostile behavior
Paranoid thoughts
Psychotic symptoms
Behavioral Signs
Diminished interest in previously enjoyed activities or pursuits
Observable decline in personal hygiene and grooming standards
Reduced appetite or unintentional weight loss
Abrupt changes in social associations or interests
Decreased academic or occupational performance
Diagnosing Inhalant Use Disorder
Diagnosing inhalant use disorder according to the DSM-5 involves identifying a problematic pattern of inhalant use that leads to significant impairment or distress. Clinicians look for at least two of the eleven criteria listed above within a 12-month period.
Depending on how many criteria a person meets, the condition is classified as mild (2-3 symptoms), moderate (4-5 symptoms), or severe (6 or more symptoms). When a person is diagnosed with moderate or severe IUD, it is considered an addiction and treatment is crucial.
The diagnosis can also indicate whether an individual is in early or sustained remission, based on how long they have abstained from inhalant use, and whether they are in a controlled environment that restricts access to inhalants.
Causes
Like all substance use disorders, the exact cause of IUD is not known, but thought to be the result of a combination of factors that increase vulnerability to developing the condition. Even one of these factors can increase the risk of inhalant use disorder emerging, yet the more factors affect an individual, the more risk there is of them compounding and leading to addiction.
Individual susceptibility to substance use disorder is influenced by multiple factors, such as biological traits, genetics, abnormal brain development, social and economic instability, unique personality traits (such as neuroticism), and the presence of co-occurring mental health conditions. [6]
These influences are also shaped by wider social conditions, including the degree of family and community support, experiences of discrimination or marginilization, societal attitudes toward drug use, and the availability and legal regulation of inhalants - all of which can either protect against or increase the risk of developing inhalant use disorder. [6]
Biological Traits
In terms of inhalant use disorder, biological factors include gender, genetics, hormones, brain function, and other physiological characteristics that contribute to individual vulnerability. Studies indicate females tend to have higher rates of inhalant use, while males are more prone to engaging in risky behaviors, and tend to abuse volatile substances for longer. [4] [6]
Genetics
Recent studies indicate that genetic factors account for roughly half of the overall risk for drug addiction, including inhalant use disorder, with specific genes influencing susceptibility to particular substances. These genetic influences impact both the way drugs are metabolized and the communication between nerve cells through brain chemicals. [6]
Abnormal Brain Development
Exposure to drugs (particularly during fetal development or early childhood) can increase the brain’s susceptibility to inhalant addiction during adolescence or adulthood. This heightened vulnerability is partly due to the disruption of normal brain development, which can affect decision-making, impulse control, and reward sensitivity. [6]
Social and Economic Instability
Research indicates that the risk of developing IUD is higher in environments marked by social and economic instability (such as familial dysfunction, poverty, unemployment, corruption, high crime rates, natural disasters, or war) where there is high stress, limited social support, easy access to drugs, and few opportunities for healthy recreation. [6]
Co-Occurring Mental Health Conditions
The presence of a pre-existing mental health condition raises the likelihood of developing an addiction to inhalants, as individuals with psychiatric disorders may turn to volatile substances in an attempt to self-medicate. This tendency is often reinforced by symptoms such as difficulty coping with stress, emotional regulation challenges, and impulsive behavior. [6]
Who is Likely to Develop an Inhalant Addiction?
Inhalant use is often overlooked as an addiction, yet the substances are legal, inexpensive, and widely available, making the abuse of these chemicals common among young people and low-income communities. [4]
Chronic users usually face multiple disadvantages, including troubled family backgrounds, emotional struggles, economic difficulties, and social problems. Like other substance addictions, inhalant use often arises as an unhealthy coping mechanism in the face of significant hardship. [3]
Recent data shows that middle and high-school-aged populations are more likely to develop an inhalant addiction, with those most at risk often having been exposed to poverty, instability, or abuse. A 2021 study showed the following use rates, which typically decline with age: [3] [4]
8th graders make up the highest use rate at just over 3.5%
10th graders show a nearly 2.5 % use rate
12th graders drop down to just under 2% use rate
Inhalant abuse is also commonly found in low-income communities (particularly low-income youth living on the streets), where factors such as unemployment, lack of education, and limited access to resources contribute to higher inhalant abuse rates. [4]
High use has also been recorded in marginalized indigenous communities in both Australia and North America, where between 50 to 60% of adolescents have tried petrol sniffing. This is again thought to be linked more to poverty, unemployment, and isolation than cultural traditions. [3]
Furthermore, some studies show that people in large metropolitan areas and those housed in psychiatric hospitals, prisons, and residential care facilities often report high rates of inhalant use. [4]
How Dangerous is Inhalant Abuse?
Like all drug abuse, inhaling volatile substances can affect multiple body systems, producing both short and long term consequences. These risks vary from individual to individual, depending on factors such as body size, weight, overall health, and tolerance levels.
Other variables include the specific type of inhalant, potential interactions with other substances, the quantity used, physical activity before or after use, and the amount of fresh air inhaled during exposure.
That said, inhalant use is considered among the most dangerous of all substances, as inhaling chemicals can lead to an overdose after just a single use of the drug. In other words, it is possible to try inhaling a substance for the first time, and suffer immediate death.
Short Term Dangers
Although individuals who abuse inhalants are typically seeking relief in the form of intoxication, the short term dangers far outweigh the temporary euphoria. “Acute intoxication,” can not only result in fatality, but lead to hospitalization due to a host of distressing short-term effects, including: [7]
Double vision
Slurred speech
Headache or vertigo
Loss of coordination or clumsiness
Dizziness or lightheadedness
Confusion or trouble thinking clearly
Seeing or hearing things that are not real (hallucinations)
Seizures, stupor, or even coma in severe cases
Heart palpitations or racing heartbeat
Irregular heart rhythms
Difficulty breathing, wheezing, or coughing
Lung irritation or inflammation
Bluish or discolored skin, especially in fingers and toes (from certain inhalants)
Can a Person Overdose on Inhalants?
Repeatedly inhaling chemicals or even using an inhalant just once, can lead to acute intoxication, also known as an inhalant overdose. There are two different forms of overdose commonly resulting from inhalant abuse - sudden sniffing death, and suffocation. [4]
Sudden Sniffing Death
Inhalant overdoses can happen at any time, even during a person’s very first use. This is often referred to as sudden sniffing death, a condition in which the toxic chemicals trigger fatal cardiac arrest. Each year, an estimated 200 deaths in the United States are linked to inhalant abuse, though the actual number may be higher since many cases go unreported or are misclassified. [4]
Sudden sniffing death is most often associated with the abuse of propane, butane, and other aerosol chemicals. These substances are particularly dangerous because they can cause the heart to suddenly stop beating, even in otherwise healthy individuals, with no warning and regardless of the amount inhaled. [8]
Suffocation
Both suffocation and sudden sniffing death are serious risks with inhalant use, but suffocation is one of the most common and immediate causes of death linked to inhalant use. Breathing in gases within enclosed spaces, or using inhalation methods such as placing a plastic bag over the head, can displace oxygen in the lungs and result in suffocation. [9]
This happens when a person inhales so much of the chemical vapors that there is not enough oxygen left for the body to breathe, leading to unconsciousness and potentially death. Additionally, certain inhalants are so cold or pressurized that they can freeze the throat and airways on contact, causing swelling or blockage that makes it impossible to breathe. [9]
Emergency Response To Inhalant Overdose
If you or someone you know shows any of the dangerous short-term symptoms listed above, call emergency services immediately. Once an ambulance has arrived, the person should be kept in a safe environment under medical supervision until they are fully stabilized, which may take 2 to 4 hours or longer depending on the severity of inhalant overdose.
Long-Term Dangers
In addition to potential for overdose and other short term consequences of inhalant use, according to studies, using volatile substances regularly can cause the following long-term health complications: [4] [6]
Impaired brain development during adolescence
Problems with thinking, memory, and learning
Trouble with balance, walking, or coordination
Numbness, tingling, or burning sensations in hands and feet
Muscle weakness and loss of strength
Seizures or sudden convulsions
Confusion, poor concentration, and delusional thinking
Vision problems, including possible blindness
Ringing in the ears or permanent hearing loss
Kidney damage, which can cause flank pain, reduced urination, or buildup of toxins in the body
Liver damage, which may present as fatigue, nausea, vomiting, abdominal pain, fever, or yellowing of the skin and eyes
Severe muscle breakdown, which can cause extreme weakness
For female users: Disruptions in reproductive health
Treatment Options
In light of the fact that inhalant use disorder affects many aspects of life, treatment typically requires a comprehensive approach. For most individuals, a combination of therapy (either individual or group) and, in some cases, medication is the most effective strategy. In more severe cases, admission to a 12-step inpatient treatment program may be recommended. [10] [11]
Treatment plans that address a person’s specific circumstances (including medical and mental health, along with socioeconomic factors) provide the greatest likelihood of lasting recovery. Therefore, whether pursuing inpatient or outpatient care, it is important to choose healthcare providers who have expertise in both addiction as well as other psychiatric and physical conditions. [10]
Inhalant use disorder can be treated effectively, with strong evidence showing the benefits of medications, behavioral therapies, and 12-step programs for addiction recovery. As IUD is a chronic condition, ongoing management is essential, and support groups such as Narcotics Anonymous offer continued assistance for recovery maintanence. [11]
Medical Detoxification
For individuals with inhalant use disorder (particularly those who have been using volatile substances long-term or developed a high tolerance to the drug) detoxification, or detox, is often required. Medically supervised detox helps to manage withdrawal safely, through both the use of medications and by monitoring a person’s vital signs throughout the process.
Symptoms of inhalant withdraw tend to worsen two to five days after stopping use, and in severe cases, can resemble alcohol withdrawal, especially for chronic users of substances like toluene. Common withdrawal symptoms can include: [7]
Shaking or tremors
Feeling irritable or easily annoyed
Anxiety or nervousness
Trouble sleeping
Confusion or disorientation
Tingling sensations (“pins and needles”)
Seizures
Muscle cramps or aches
Chills or cold feelings
Headaches
Nausea or stomach pain
General discomfort or vague abdominal pain
Medication
While no FDA-approved pharmaceuticals specifically designed to treat inhalant use disorder exist, drugs including antipsychotics and mood stabilizers are often used to manage coexisting mental health conditions such as inhalant intoxication, inhalant-induced psychotic disorder, and other related psychiatric issues, alongside treatments such as therapy, inpatient and outpatient programs, or 12-step support groups.
Therapy
After detoxification, therapy is often employed to treat IUD, with the most effective form shown to be various types of behavioral therapy. Within this therapeutic umbrella, the most frequently employed approaches include motivational interviewing, cognitive behavioral therapy (CBT), contingency management, and support groups such as Narcotics Anonymous. [11]
Motivational Interviewing (MI)
Approximately 40% of active addicts indicate that they are not willing or ready to stop using substances. Motivational interviewing is a form of therapy designed to enhance a person’s motivation to change, and it is supported by strong evidence. In the short term, it is more effective than receiving no treatment, though its long-term benefits are less well established. [11]
Contingency Management (CM)
Contingency management works on the principle that providing immediate and predictable rewards (such as goods or money) for remaining drug-free can motivate recovery. This approach has proven effective for treating various substance use disorders, with longer-term programs typically producing better results. [12]
Cognitive Behavioral Therapy (CBT)
Cognitive behavioral therapy (CBT) is considered the gold standard for individuals with inhalant use disorder, helping them identify and shift the underlying thought patterns that are linked to substance abuse. However, research indicates that CBT alone may be less effective for IUD in comparison to other 12-step programs, such as Narcotics Anonymous. [13]
Narcotics Anonymous (NA)
Support groups, particularly Narcotics Anonymous, are an important part of recovery and ongoing abstinence for individuals with inhalant dependence. This is shown in a 2018 survey by NA World Services of 28,495 members, which found that participants in the program reported an average of just of 11 years of continuous recovery maintainance. [14]
Outpatient Programs
Outpatient treatment is a form of care where individuals receive structured support, therapy, and medical monitoring for inhalant use disorder while continuing to live at home and maintain their daily routine. Outpatient programs are generally most suited to individuals with mild to moderate substance use disorder, though results can vary between people.
There are different levels of outpatient care, including:
Partial Hospitalization Program (PHP)
PHPs provide structured, daytime treatment for individuals with inhalant use disorder while allowing them to live at home, offering therapies and support similar to inpatient care but with lower cost and flexibility.
Intensive Outpatient Program (IOP)
IOPs offer several hours of therapy per week, focusing on relapse prevention and stress management, and are often used as a step down from PHP or residential treatment for individuals with moderate inhalant use disorder.
Standard Outpatient Program (SOP)
SOPs provide a lower-intensity, ongoing support option for individuals with mild inhalant use disorder or those finishing more intensive programs, emphasizing relapse prevention and coping skills while allowing participants to maintain daily responsibilities.
12-Step Residential Treatment and Sober Living Communities
In light of the fact that inhalants are so easily accessible, individuals with moderate to severe inhalant use disorder can benefit most from inpatient rehabilitation, particularly when paired with a 12-step program. These centers provide a secure environment to begin recovery with strictly prohibited access to substances.
Inpatient facilities can medically manage withdrawal and inhalant-induced psychosis, offering a combination of therapy, medication, and peer support. Following treatment, transitioning into a sober living environment, colloqially known as a “halfway house,” can help individuals adjust to daily life and maintain recovery while reintegrating into society.
Support Groups
Depending on the severity of the inhalant use disorder, twelve-step support groups, particularly Narcotics Anonymous, can highly benefit recovery from inhalant addiction either alone or as part of a broader treatment plan. Their effectiveness is largely influenced by peer support, guidance from sponsors, and observing others who have successfully maintained sobriety. [15]
Being part of a community facing similar challenges can lessen feelings of shame, guilt, and loneliness, while exposing recovering addicts to others’ success stories, thereby instilling a sense of hope and motivation. These programs also promote healthier social connections, boost confidence in one’s ability to stay drug-free, and reduce impulsive behavior and cravings. [15]
Helping a Loved One with an Inhalant Use Disorder
Discovering that a loved one has an inhalant use disorder can create a sense of helplessness and overwhelm. However, keep in mind that it is entirely natural to feel anxious and distressed in the face of circumstances beyond one’s control. Even if you are not sure of how to approach the situation, a loved one’s support can have a meaningful impact on the path to recovery.
Here are a few tips for helping a loved one with an inhalant use disorder:
Show Care: Address the issue verbally with compassion and encourage your loved one to seek professional help to improve the chance of successful treatment.
Offer Understanding: Listen without judgment and refrain from expressing frustration or blame, focusing instead on building trust by offering acceptance and understanding.
Create a Safe Environment: Remove or lock up inhalants at home, while keeping track of missing items, to reduce temptation and support recovery.
Uphold Boundaries: Refuse to enable inhalant use and implement accountability measures, such as agreeing on rules and consequences surrounding substance use.
Practice Loving Detachment: Recognize that recovery is a gradual process and that some setbacks are normal and should not be taken personally.
Focus on Self-Care: Take care of your own emotional well-being to remain a strong and effective source of support.
Aftercare and Long-Term Recovery
Early recovery from IUD requires deliberate changes in daily routines to reduce the risk of relapse. Adopting supportive strategies, such as attending regular recovery meetings, avoiding situations where inhalants are accessible, and engaging in safe, rewarding alternatives, can reinforce the desire to stay substance-free.
Attend 90 Meetings in 90 Days
The first year of recovery from inhalant use disorder is a particularly high-risk period for relapse. In light of this, it is recommended by Narcotics Anonymous to go to 90 meetings in 90 days after leaving treatment or joining a recovery fellowship. This ongoing support can help individuals in early recovery stay focused and maintain sobriety.
Avoid Pro-Inhalant Social Situations
Spending time in places where inhalants are likely to be abused has led many people with inhalant use disorder to relapse, even when thier intention was purely to socialize. While it is not impossible to recover while surrounded by those still in active addiction, wherever possible, it is best to focus on surrounding yourself with people living a happy, drug-free lifestyle.
Use Eco-Friendly Cleaning Products
Acknowledging one’s vulnerability to inhalant addiction is essential for moving forward and maintaining recovery. Keeping inhalants or other addictive substances at home is unwise, as easy access can trigger cravings and obsessive thoughts, particularly in early recovery. For this reason it is recommended to replace all addictive household substances with eco-friendly or non-chemical products.
Stay Alert for Cross-Addiction
When ceasing inhalant use, it is imperative to remain vigilant of the risk of replacing one addictive substance with another, a phenomenon known as cross-addiction. This can include turning to other substances or behaviors (such as gambling, overeating, or excessive online activity) as unhealthy coping tools in the face of cravings.
Connect With Others
Building connections with family, friends, or new peers in a recovery fellowship can be a strong support in overcoming inhalant use disorder. Positive relationships provide a sense of belonging and help reduce isolation, which can trigger relapse. Socializing while substance-free can also bring enjoyment, relaxation, and a constructive way to focus energy.
Recovery Maintainance
Due to the fact that addiction permanently rewires the brain, maintaining recovery from inhalant use disorder is a lifelong commitment. Fortunately, actively participating in supportive practices, such as those provided by recovery fellowships like Narcotics Anonymous, has been found to boost success rates significantly.
By attending support group meetings regularly, and following the guidance of a sponsor, along with taking part in fellowship events and daily self-reflection can help individuals maintain sobriety from inhalant addiction and handle ongoing challenges. These supports create accountability, connection, and structure, all of which are crucial for long-term recovery.
Attend Two to Four Meetings a Week
After an initial period of 90 meetings in 90 days, it is recommended to attend recovery meetings consistently in order to counteract denial, build accountability, reduce feelings of isolation, express challenges, and subsequently lower the chance of relapse. Meetings also provide a safe place to share experiences and learn new strategies for staying sober.
Sponsor (Mentor) Guidance
A sponsor acts as a mentor who has already navigated a substantial period of recovery and can provide direction during moments of temptation. Sponsors offer personalized guidance, helping individuals recognize harmful thought patterns and stay focused on their recovery goals. Regular check-ins with a sponsor can serve as an important source of accountability.
Final Thoughts
Inhalant use disorder is a psychiatric condition that occurs when individuals deliberately inhale chemicals, often found in everyday products like deodorant or felt-tip markers, to experience intoxication. Though less well-known than other addictions, IUD can have devastating health effects, including sudden death.
Fortunately, effective treatment options exist, ranging from outpatient programs and behavioral therapies to residential treatment, medication, and support groups like Narcotics Anonymous. With professional treatment, aftercare, and personal commitment, people with inhalant use disorder can recover and go on to not only live healthy and fulfilling lives, but to thrive.
References
1.
Inhalant abuse
L Baydala. (2010). Inhalant abuse. Paediatrics & Child Health, 15(7), 443. https://pmc.ncbi.nlm.nih.gov/articles/PMC2948777/
Source: Paediatrics & Child Health
2.
Inhalant Use and Inhalant Use Disorders in the United States
Howard, M. O., Bowen, S. E., Garland, E. L., Perron, B. E., & Vaughn, M. G. (2011). Inhalant Use and Inhalant Use Disorders in the United States. Addiction Science & Clinical Practice, 6(1), 18. https://pmc.ncbi.nlm.nih.gov/articles/PMC3188822/
Source: Addiction Science & Clinical Practice
3.
Inhalant abuse among adolescents: neurobiological considerations
Lubman, D. I., Yucel, M., & Lawrence, A. J. (2008). Inhalant abuse among adolescents: neurobiological considerations. British Journal of Pharmacology, 154(2), 316-326. https://bpspubs.onlinelibrary.wiley.com/doi/10.1038/bjp.2008.76
Source: British Journal of Pharmacology
4.
Inhalant Addiction Statistics - Inhalant Abuse Demographics (2025)
Miller, J. (2025). Inhalant Addiction Statistics - Inhalant Abuse Demographics (2025). AddictionHelp.com. https://www.addictionhelp.com/inhalants/statistics/
Source: AddictionHelp.com
5.
Diagnostic and statistical manual of mental disorders (5th ed.)
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). https://psychiatryonline.org/doi/book/10.1176/appi.books.9780890425596
Source: American Psychiatric Association
6.
Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Volkow, N. D., & Blanco, C. (2023). Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry, 22(2), 203-229. https://onlinelibrary.wiley.com/doi/10.1002/wps.21073
Source: World Psychiatry
7.
Inhalants Clinical Presentation: History, Physical, Causes
Jauch, E. C. (2025, April 10). Inhalants Clinical Presentation: History, Physical, Causes. Medscape.com; Medscape. https://emedicine.medscape.com/article/1174630-clinical
Source: Medscape
8.
Inhalants WHAT ARE INHALANTS?
Inhalants WHAT ARE INHALANTS? (2020). https://www.dea.gov/sites/default/files/2020-06/Inhalants-2020_1.pdf
9.
ADF - Drug Facts - Inhalants
Alcohol and Drug Foundation. (2015, December 31). ADF - Drug Facts - Inhalants. ADF - Alcohol & Drug Foundation. https://adf.org.au/drug-facts/inhalants/
Source: ADF - Alcohol & Drug Foundation
10.
What is a substance use disorder?
American Psychiatric Association. (2024). What is a substance use disorder? Psychiatry.org. https://www.psychiatry.org/patients-families/addiction-substance-use-disorders/what-is-a-substance-use-disorder
Source: Psychiatry.org
11.
Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Volkow, N. D., & Blanco, C. (2023). Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry, 22(2), 203-229. https://onlinelibrary.wiley.com/doi/10.1002/wps.21073
Source: World Psychiatry
12.
Principles of drug addiction treatment: A research-based guide (Third Edition)
National Institute on Drug Abuse. (2014). Principles of drug addiction treatment: A research-based guide (Third Edition). https://nida.nih.gov/sites/default/files/podat-3rdEd-508.pdf
Source: National Institute on Drug Abuse
13.
An update on the evidence for Alcoholics Anonymous participation
An update on the evidence for Alcoholics Anonymous participation. (n.d.). Recovery Research Institute. https://www.recoveryanswers.org/research-post/update-evidence-alcoholics-anonymous-participation/
Source: Recovery Research Institute
14.
Alcoholics anonymous and other 12-step programs for alcohol use disorder
Kelly, J. F., Humphreys, K., & Ferri, M. (2020). Alcoholics anonymous and other 12-step programs for alcohol use disorder. Cochrane Database of Systematic Reviews, 3(3). https://recovery-iowa.org/wp-content/uploads/2021/10/2020-Review-of-Scientific-Studies-on-NA.pdf
Source: Cochrane Database of Systematic Reviews
15.
Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention
Volkow, N. D., & Blanco, C. (2023). Substance use disorders: A comprehensive update of classification, epidemiology, neurobiology, clinical aspects, treatment and prevention. World Psychiatry, 22(2), 203-229. https://onlinelibrary.wiley.com/doi/10.1002/wps.21073
Source: World Psychiatry

Author
Star GorvenStar Gorven is a wellness and mental health writer with a talent for crafting evocative and evidence-based content across a wide range of topics. Her work blends analytical research with imagination and personality, offering thoughtful insights drawn from her exploration of subjects such as psychology, philosophy, spirituality, and holistic wellbeing.
Activity History - Last updated: April 10, 2026, Published date: March 19, 2026

Reviewer
Dr. Jennifer Brown is dual board-certified in family medicine and obesity medicine. She currently works for Amwell Medical Group, providing virtual primary care services, including mental health treatment.
Activity History - Medically reviewed on April 10, 2026 and last checked on April 10, 2026

